AOBCOHORT8
top of page
wilsonsonsini.jpeg

Athena on Boards | Cohort 8

December 2021 - April 2022 | POWERED BY WILSON SONSINI

VIKA BROUGH

SVP of Finance

Prometheus Biosciences

CRIS CALSADA

Chief Financial Officer

Regulus Therapeutics

JENNIFER COHEN

Associate Director

Takeda Development Center

NEHA GIRI

Software Architect

Intuit

JOCELYN HAYES

Managing Director, Digital & Operating Model Transformation & Value Realization

Platinum ERP

JULIE HOFFMEISTER

CEO & Principal Consultant

Hoffmeister Consulting

IRENE HSIEH

Director, Regulatory Affairs

ChromaCode Inc

ERIKA LAWSON

Senior Director, Program Management

Qualcomm

CYNTHIA LONG

Senior Manager, Center of Excellence

Intuit

CAROLINE MACSALKA

Director, Corporate Development

Emergent BioSolutions

ANITA MATHIAS

Vice President, Clinical Pharmacology & Development

Gossamer Bio

NAOMI O'GRADY

Sr. Director Global Portfolio Strategy

Foundation Medicine

LESLIE SCHULTZ

Head of Human Resources US and Costa Rica

Midland Credit Management

LAURA SINGER

Vice President, Quality Assurance

Heron Therapeutics, Inc.

EILEEN SUN

Senior Director Program Management

aTyr Pharma

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

JENNIFER FANG

Partner

Wilson Sonsini

GIOIA MESSINGER

Founder

LinkedObjects | Board Director

RENEE TANNENBAUM

Senior Advisor

Board Director

Athena on Boards Committee

CO-CHAIR

JAYE CONNOLLY-LABELLE

CEO

RippleNami Inc.

CO-CHAIR

CHARITY WILLIAMS

Partner

Cooley

​

SHIRIN ALIPANAH

Principal

Avasant

​

GRACE CHUI-MILLER

Chief Financial Officer

Correlation Ventures

​

BO MONACO

Audit Partner

BDO

bottom of page